| [1] |
郑成竹，丁丹．肥胖症及代谢疾病的外科手术治疗[J].中国实用外科杂志, 2010, 30(3):173-175.
|
| [2] |
Ali Aboel Dahab, Dhia El-Hag, Moutamed Gamal M., et al. Pharmacokinetic variations in cancerpatients with liver dysfunction: applications and challenges of pharmacometabolomics[J]. Cancer Chemotherapy and Pharmacology, 2016:1-25.
|
| [3] |
Nicholson JK, Lindon JC, Holmes E. Metabonomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data[J]. Xenobiotica, 1999, 29(11):1181-1189.
|
| [4] |
Nicholson JK, Connely J, Lindon JC, et al. Metabonomics: a platform for studying drug toxicity and gene function[J]. Nat Rev Drug Discov, 2002, 1(2):153-161.
|
| [5] |
Holmes E, Antti H. Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra[J]. Analyst, 2002, 127(12):1549-1557.
|
| [6] |
ZHOU Ning, YAN Xian-zhong. Metabonomics-based methods for metabolic disease: research advances[J]. Int Pharm Res, 2015, 10(5): 561-573.
|
| [7] |
Ellis D I, Dunn W B, Griffin J L, et al. Metabolic fingerprinting as a diagnostic. [J].Pharmacogenomics, 2007, 8(8):1243-66.
|
| [8] |
German JB, Bauman DE, Burrin DG, et al.Metabolomics in the opening decade of the 21st century: building the rodes to individualized health[J]. J Nutr, 2004, 134(10):2729-2732.
|
| [9] |
Nobeli I, Thornton J M. A bioinformatician's view of the metabolome [J]. Bioessays, 2006, 28(5):534-45.
|
| [10] |
Mastrangelo A, Panadero M I, Pérez L M, et al. New insight on obesity and adipose-derived stem cells by comprehensive metabolomics[J]. Biochemical Journal, 2016, 473(14).
|
| [11] |
Reinehr T, Wolters B, Knop C, et al. Changes in the serum metabolite profile in obese children with weight loss[J]. European Journal of Nutrition, 2015, 54(2):173-181.
|
| [12] |
Mihalik S J, Michaliszyn S F, Heras J D L, et al. Metabolomic Profiling of Fatty Acid and Amino Acid Metabolism in Youth With Obesity and Type 2 Diabetes: Evidence for enhanced mitochondrial oxidation[J]. Diabetes Care, 2012, 35(3):605-611.
|
| [13] |
Takashina C, Tsujino I, Watanabe T, et al. Associations among the plasma amino acid profile, obesity, and glucose metabolism in Japanese adults with normal glucose tolerance[J]. Nutrition & Metabolism, 2016, 13(1):1-10.
|
| [14] |
Narath S H, Mautner S I, Eva S, et al. An Untargeted Metabolomics Approach to Characterize Short-Term and Long-Term Metabolic Changes after Bariatric Surgery[J]. Plos One, 2016, 11(9):1-18.
|
| [15] |
Hanzu F A, Vinaixa M, Papageorgiou A, et al. Obesity rather than regional fat depots marks the metabolomic pattern of adipose tissue: An untargeted metabolomic approach[J]. Obesity, 2014, 22(3):698-704.
|
| [16] |
刘金刚，郑成竹，王勇. 中国肥胖和2型糖尿病外科治疗指南(2014)[J]. 中国实用外科杂志, 2014, 8(11):499-504.
|
| [17] |
Geidenstam N, Danielsson A P, Spégel P, et al. Changes in glucose-elicited blood metabolite responses followingweight loss and long term weight maintenance in obese individuals with impaired glucose tolerance[J]. Diabetes Research & Clinical Practice, 2016, 113:187-197.
|
| [18] |
Nicholson JK, O'Flynn MP, Sadler PJ, et al. Proton-nuclearmagnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects[J]. Biochem J, 1984, 217(2):365-375.
|
| [19] |
Zhao H, Li Z, Tian G, et al. Effects of traditional Chinese medicine on rats with typeⅡdiabetes induced by high-fat diet and streptozotocin: a urine metabonomic study[J]. Afr Health Sci, 2013, 13(3):673-681.
|
| [20] |
Park S, Sadanala K C, Kim E K. A Metabolomic Approach to Understanding the Metabolic Link between Obesity and Diabetes[J]. Moleculer Cells, 2015, 38(7):587-596.
|
| [21] |
Men L, Pi Z, Zhou Y, et al. Urine metabolomics of high-fat diet induced obesity using UHPLC-Q-TOF-MS[J]. Journal of Pharmaceutical & Biomedical Analysis, 2016, 132:258.
|
| [22] |
马颖. 肥胖与高血压、高脂血症、高血糖的相关性探析[J]. 中国实用医药, 2013, 8(25):240-241.
|
| [23] |
Henry S L, Benjamin B, Wood‐Bradley R J, et al. Developmental origins of obesity-related hypertension[J]. Clinical & Experimental Pharmacology & Physiology, 2012, 39(9):799.
|
| [24] |
Graessler J, Schwudke D, Schwarz P E,etal. Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. PLoS ONE, 2009, 4(7): e6261.
|
| [25] |
Bovo S, Mazzoni G, Galimberti G, et al. Metabolomics evidences plasma and serum biomarkers differentiating two heavy pig breeds[J]. Animal, 2016, 10(10):1-8.
|
| [26] |
王文，商卓.高尿酸血症与高血压的关系[J].中国心血管杂志, 2016, 21(2):424-425.
|
| [27] |
刘英，曾勇. 高尿酸血症与肥胖[J]. 中国心血管杂志, 2016, 21(1): 11-13.
|
| [28] |
ZHONG Qi, GAO Yuxia, CHANG Hong. Plasma Metabonomics Analysis of Male Patients with Hyperuricemia.Tianjin medica[J]. 2011, 8(8):695-697.
|
| [29] |
Yu Xuefeng, Chen Kaiyun, Tong Ying. Lipid metabolism study of hyperuricemia and gout arthritis basedon lipidomics technology. World Latest Medicne Information (Electronic Version). 2016 Vol. 16 No. 7.
|
| [30] |
胡晓飞，倪银星，祝之明,等. 肥胖与阻塞性睡眠呼吸暂停综合征相关性的研究进展[J].中华老年心脑血管病杂志, 2009, 11(10): 819-820.
|
| [31] |
刘卫芳，袁观远，霍仁涛,等. 串联质谱分析在阻塞型睡眠呼吸暂停低通气综合征中的意义[J].医学与哲学, 2015, 36(20):41-44.
|
| [32] |
徐芳，侯丽辉，郝松莉,等. 多囊卵巢综合征代谢组学研究进展[J].中国实用妇科与产科杂志, 2016, 32(5):489-494.
|
| [33] |
王廷峰，郑成竹，张鹏,等. 减重手术治疗多囊卵巢综合征研究进展[J].中国实用外科杂志, 2014(11):1099-1102.
|
| [34] |
胡婷.多囊卵巢综合征的病因研究进展[J/CD].中华妇幼临床医学杂志:电子版, 2016, 12(3):360-363.
|
| [35] |
Sun L, Hu W, Qiao L, et al. Metabonomics Reveals Plasma Metabolic Changes and Inflammatory Marker in Polycystic Ovary Syndrome Patients[J]. Journal of Proteome Research, 2012, 11(5): 2937-46.
|
| [36] |
黄莉吉，谢绍锋，刘超.肥胖相关性肾病的研究进展[J].国际内分泌代谢杂志, 2015, 35(3): 180-182.
|
| [37] |
王琳琳，郑凌云，张磊,等. 高果糖诱导大鼠胰岛素抵抗模型的胰腺组织代谢组学研究[J].南方医科大学学报, 2014, 34(9):1301-1304.
|